Health & Nutrition

bg
Do Cranberries and Pumpkin Seeds Help an Enlarged Prostate?

Do Cranberries and Pumpkin Seeds Help an Enlarged Prostate?

Cranberries and pumpkin seeds are put to the test for benign prostatic hypertrophy....

bg
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8...

The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and...

bg
UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs

UnitedHealth blows past estimates, hikes earnings outlook...

The healthcare giant is working to stabilize margins by shrinking membership, exiting...

bg
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways

J&J falls despite a beat-and-raise quarter. Why we're raising...

Johnson & Johnson's quarter was imperfect, but enough is going right to validate...

bg
The Science Behind Oatmeal and Diabetes

The Science Behind Oatmeal and Diabetes

Before Insulin, There Was Oatmeal Before the discovery of insulin, the lives of...

bg
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

A tiny GLP-1 implant is the latest bet to help patients...

Vivani Medical is developing an implant of semaglutide, the active ingredient in...

bg
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

AstraZeneca's trial flop raises a bigger question: Is its...

For years, AstraZeneca has commanded one of the richest valuations among large European...

bg
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC

Abivax $920 million cash haul lets it prepare for solo...

Its latest fundraising round provides the French biotech with enough cash to finance...

bg
A Surprising Vegetable Approach to Insomnia

A Surprising Vegetable Approach to Insomnia

Lactucin, the hypnotic component of lettuce, is put to the test in a randomized,...

bg
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs — many are finding ways around it

Healthy Returns: Employers aren't expanding coverage of...

About 36% of employers said they provide coverage of GLP-1s for both diabetes and...